A new study suggests that mineral metabolites may reflect prognosis in patients with kidney disease. These metabolites hold promise as targets for therapy. John Schieszer reports in today’s Medical Minute that higher baseline levels of the metabolites are linked to an increased risk for kidney failure or death independent of kidney function.